ARTICA Therapeutics

About ARTICA Therapeutics

ARTICA Therapeutics and its seasoned team started operatons in 2020 and was supported by pre-Seed financing from BioGeneration Ventures. Artica is dedicated to developing novel small molecule medicines for inflammatory and autoimmune indicatons. Artca is at the forefront of covalent binding technology as well as in label-free cellular-based screening approaches. The unique combinaton of these capabilities allows rapid progression of the best drug candidates that have unprecedented and superior characteristics, creating novel and highly selective therapies for patients with unmet medical need.

Address

• Headquarters

  Robert Boyleweg 42333CG LeidenZuid-Holland, Netherlands

Team by function

Based on 19 public job profiles as of 4 September 2026.

• Research / R&D11
• Executive / C-Suite4
• Administrative / Office1
• Finance / Accounting1
• Founder / Owner1
• HR / People / Recruiting1